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 “Last year (2001) will be identified in the history of biology by the publication of
the first draft of the complete sequence of the human genome”(Collado-Vides and
Hofestaedt 2002, vii) (Collado-Vides and Hofestaedt 2002, vii).
“The more we lift the lid on the human genome, the more vulnerable to
experience genes appear to be” (Ridley 2003).
1. Introduction
In '1953 and all that', one of the seminal papers on the relationship between classical and
molecular genetics, Philip Kitcher argued that while molecular genetics has solved the
major questions of replication, mutation and the action of genes these celebrated
achievements do not fall into either of the traditional categories of theory reduction and
explanatory extension (Kitcher 1984). The classical and molecular conceptions of the
gene both remain valid. For the last 15 years C. Kenneth Waters has argued relentlessly
against the antireductionist consensus that Kitcher helped create (Waters 1990, 1994,
2000, forthcoming a, forthcoming b). According to Waters the molecular gene concept
“unifies our understanding of the molecular basis of a wide variety of phenomena,
including the phenomena that classical genetics explains in terms of gene differences
causing phenotypic differences” (Waters 1994, 163). He identifies the privileged role of
the molecular gene in many biological explanations as that of an “actual difference
maker” with “causal specificity” (Waters forthcoming b). I will argue that while Waters
may have offered an accurate analysis of the role and status of the molecular gene
concept during the classical period of molecular genetics from the 50s to the 70s, his
account clearly downplays some of the major theoretical insights into genome structure
or function revealed by contemporary molecular genetics and genomics, including
surprising ways in which DNA performs its traditional gene-like functions, new un-gene-
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like functions, and other cellular structures that may share some of DNA’s cellular
function. These revolutionary findings have propelled us into a new scientific era of
'postgenomic' biology. Its ‘postgenomic gene’ concept embodies the continuing project of
understanding how genome structure supports genome function but with a deflationary
picture of the gene as a structural unit and causal agent and a massively increased role for
regulatory mechanisms including its environmental signaling pathways. The complex
cellular regulation of genome expression forces us to distinguish a gene or protein’s
“molecular function” from its contingent “cellular function” (Marcotte 2002). It is one
aim of systems biology to study the location, time and condition of these genes and
proteins’ expression, the networks of their interaction and the systemic context in which
they operate. The distributed control of genome expression, the extent to which it
amplifies the literal coding sequence of the “reactive genome”1 by providing additional
sequence specificity to an underspecified DNA sequence, extends the range of
“constitutive epigenesis”2 all the way down to the molecular level of sequence
determination.
There is reason to believe that as much as 1953 marked the starting point of molecular
genetics (Watson and Crick 1953a, 1953b), 2001 will come to signify the advent of
postgenomic or systems biology (Lander et al. 2001; Venter et al. 2001). The Human
Genome project, while sequencing the whole genome, highlighted molecular genetics’
obsession of the last 50 years with identifying and annotating protein coding genes. In
both a positive and a negative sense the final draft marked the climax of this old era, the
end of the ‘Century of the Gene’ (Keller 2000), and the beginning of the post-genome
era. On the positive side the sequence of the human genome, along with other sequenced
genomes, have revolutionized molecular biology especially with respect to sequencing
technology and its impact on fields like comparative genomics and molecular evolution.
Biodiversity studies expanded enormously thanks to genomics, and when genome data
made it clear that variation had hardly been tapped, it was genomics that supplied the
technology and analyses that formed the basis of a radically new approach
                                                 
1 See Scott Gilbert’s quote at the end of subsection 6.2
2 For a more detailed description of constituent epigenesis see (Stotz 2006; Robert 2004).
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(metagenomics) and perhaps ultimately a new vision about the interrelatedness of all
human life (see discussions about the 'second human genome project', for example). On
the negative side, in contrast to the widespread understanding of the goal of the human
genome project as ‘decoding’ the blueprint of life the reality turned out to be much more
sobering: it merely deciphered the final draft of the code. Decoding may be eons away,
and exactly for the reasons outlined in this paper. Despite our growing knowledge of the
importance of non-coding RNA genes, both sequencing projects for practical reasons
focused on annotating protein-coding genes, for which they came up with an almost
“humiliating” small number of around 24,000, which is 1.5% of the entire genome
(Ridley 2003). Detailed studies of partial sequences revealed the complexity involved in
transcription patterns and showed us how little we know about the structure and function
of genes and other genetic elements. Genomics assaulted genetic determinism,
culminating in a much broader multilevel approach to molecular studies of life.
“In sequencing the human genome, researchers have already climbed mountains and
traveled a long and winding road. But we are only at the end of the beginning: ahead
lies another mountain range that we will need to map out and explore as we seek to
understand how all the parts revealed by the genome sequence work together to make
life” (Stein 2004, 916).
So what is the postgenomic era about? Let us recall that most of the research in molecular
genetics and medicine in the past two to three decades has been characterized by the
efforts to identify the gene(s) responsible for a given biological function or disease. The
completion of the sequencing of the human genome and at an accelerating pace of the
genomes of many other organisms signifies the change of focus from the gathering and
archiving of genomic data to its analysis and use in prediction and discovery. Comparing
the human genome with its transcriptome reveals sequence information not encoded by
the literal DNA code alone. Intra- and intercellular and even extra-organismal
environmental signals impose instructional specificity on regulatory RNAs and proteins
organized in expression mechanisms of mind-numbing complexity. The analysis of gene
regulatory networks is exactly the sort of challenge that postgenomic tools such as
bioinformatics can impact. This has undoubtedly changed the outlook of biological
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research, marking the need to approach the study of living organisms with a different
perspective. Rather than being satisfied with DNA sequence information, the focus has
shifted towards how these sequences are used in a transient and flexible way through a
network of transcriptional, co- and posttranscriptional, translational and posttranslational
mechanisms of gene expression. While the molecular decades behind us were
characterized by the attempt to decompose organisms into their smallest components, the
postgenomic era with its systems-biological outlook marks new enterprises to reassemble
these components to learn how they interact to form complex living system.
The paper will first introduce the central concept of specificity, the way it has changed
from conformational specificity in the decades of classical genetics to informational
specificity in the neo-classical era of molecular biology, and how this relates to Kenneth
Waters’ central thesis of causal specificity. This will provide the foundation for the
remainder of the paper which argues in three steps (section 3 – 5) for a new, distributed
specificity based on combinatorial control and how this is played out by the three
‘genome’ expression processes3 that I have termed sequence activation, selection and
creation. Section 6 will summarize this argument that I have based on a scientific survey
of regulatory mechanisms of genome expression and the way they impose sequence
specificity on an underdetermined DNA sequence. It will conclude with the introduction
of a deflationary, ‘postgenomic gene’ concept that sets the stage for the introduction of a
new postgenomic biology, outlined in section 7.
2. Sequence specificity and the co-linearity hypothesis
Just as 1953 didn’t mark the end of genetic analysis used in classical genetics
postgenomic biology doesn’t reduce or otherwise substitute molecular genetics and
genomics. The classical molecular gene concept was the product of a highly successful
attempt to identify the physical basis of the ‘instrumental gene’. That classical concept,
however, is embedded in biological practice in ways that would be artificially and
unhelpfully restricted by replacing it with the molecular concept. Marcel Weber
                                                 
3 This term does not presuppose the existence of a pre-defined boundary of any expressed sequence.
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concludes in his insightful comparison of Mendelian and molecular analyses of
Drosophila loci that "even though the classical gene concept had long been abandoned at
the theoretical level, it continues to function in experimental practice up to the present"
(Weber 2004, 223). What today is called ‘genetical genomics’ utilizes traditional genetic
analysis to investigate differences in the level of expression of identical genes in different
individuals, and to find the 'genes for' molecular phenotypes, such as the expression level
of some transcript. This technique reveals a wide variety of distal regulatory regions,
many of which are classical ‘genes for’ a particular phenotype but are not “nominal”
genes in its molecular sense (Griffiths et al. forthcoming). The same goes with molecular
genetics: as of Oct 13th 2006 the number of published genome sequences has reached
433, and counting (with more than 2000 running genome projects)4. The exercise of
‘counting genes’ continues in the post-genome era, if more critically reflected than before
(Stein 2001; Snyder and Gerstein 2003; Kampa et al. 2004; Kapranov et al. 2005). For
that reason Griffiths and Stotz have argued for the parallel existence of three gene
concepts: the instrumental gene, the nominal gene, and the postgenomic gene (Griffiths
and Stotz 2006). The instrumental gene has a critical role in the construction and
interpretation of experiments in which the relationship between genotype and phenotype
is explored via hybridization between organisms or directly between nucleic acid
molecules. It also plays an important theoretical role in the foundations of disciplines
such as quantitative and population genetics. The classical molecular gene concept, we
argue, developed into two current concepts with quite different functions: Richard Burian
has called the first the “nominal gene”, which is grounded in well-defined sequences of
nucleotides and a critical practical tool that allows stable communication between
bioscientists in a wide range of fields (Burian 2004). This concept, however, does not
embody major theoretical insights in genome structure or function. Most notions of
‘gene’ in this paper, if not otherwise specified, will refer to this concept. The second,
postgenomic gene concept emerged out of the ‘breakdown’ of the classical molecular
gene concept. We will encounter the genome expression mechanism responsible for this
breakdown in section 3 to 5.
                                                 
4 GOLD (Genome OnLine Database): http://www.genomesonline.org/
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Kenneth Waters’ has recently made several attempts to repeat, clarify and justify a central
thesis of his former analysis of the molecular gene concept. As I have argued elsewhere,
his central claim is no longer suitable to capture our current knowledge of genome
structure and function (Stotz 2006). Here I take issue with several of his most recent
formulations of his genetic causation model phrased in terms of “causal specificity”5:
Thesis 1: “Only the activated DNA segments (the genes) are actual difference makers of
RNA sequences“ (Waters forthcoming b, my emphasis).
Thesis 2a: “The initial synthesis of RNA in prokaryotes and eukaryotes involves many
causes, but only DNA is the causally specific actual difference maker” (Waters
forthcoming b, my emphasis).
2b: “Possible exceptions involve cases of differential RNA splicing and editing. If
differential RNA splicing occurs within the same cell structure at the same time,
then differences in the linear sequences among these polypeptides … could be
said to be caused by differences in splicing factors, rather than differences in
DNA. It would still technically be true that different "split genes" were involved”6
(Waters forthcoming a, my emphasis).
Thesis 3: “I will note that this qualifier does not need to be added for the case of genes
for RNA or polypeptides in Prokaryotes or for the case of genes for unprocessed
RNA in Eukaryotes” (Waters forthcoming a). “DNA is the causally specific
actual difference maker with respect to the population of RNA molecules first
synthesized in eukaryotic cells.” (Waters forthcoming b, emphasis in original)
Before I can react to these theses in detail in section 4 and 5, I need to clarify their central
concept of (causal) specificity.
Specificity, first for macromolecular structure and than later also for linear sequence, has
been the touchstone for modern biology. It transformed our understanding of biological
mechanism from a highly fluid and interactive process into an assembly of pieces each
                                                 
5 For argument’s sake lets pretend that I accept his general model of causation in terms of actual difference
makers.
6 This move would depart from conventional molecular genetics, and it would mean that the pre mRNA
and the RNA are specified by two different genes. Waters seems prepared to go a long way to withhold
causal specificity from splicing agents.
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with its own specific and restricted part to play (Greenspan 2001). The first half of the
last century was characterized by the concept of chemical or conformational specificity,
namely the ability of an enzyme’s binding site to recognize the chemical structure of its
specific ligands. The fewer substrates a protein can bind, the greater its specificity.
Quantum mechanics provided the necessary insight to explain the idea of structural
complementarity or a ‘key and lock system’ of recognition in terms of the
stereospecificity of enzyme and substrate to form a certain number of weak hydrogen
bonds. Molecular biology replaced this concept of specificity based on the idea of ‘form’
with a new concept of genetic specificity of nucleic acid based on the idea of
’information’ encoded in the sequence of nucleotides. This new sequence or “colinearity
hypothesis” Francis Crick laid down in the central dogma of molecular biology in 1958
and restated in Nature in 1970: “The central dogma of molecular biology deals with the
detailed residue-by-residue transfer of sequential information. It states that such
information cannot be transferred from protein to either protein or nucleic acid” (Crick
1970, 561; 1958; Sarabhai et al. 1964).
Waters’ thesis of causal specificity is basically restating Crick’s dogmatic sequence or
colinearity hypothesis in causal language and with a slight modification (namely of
reluctantly accepting splicing agents to share this specificity in certain cases). In the light
of the developments of the last 35 years (see below) this appears as an attempt to ‘rescue’
DNA as the (more or less) sole bearer of causal specificity in order to a) justify “why so
much research attention in developmental biology is centered on DNA”, and b) to “reveal
the fallacy of causal parity arguments” (Waters forthcoming b). Al Hershey, who’s
experimental results finally convinced the majority that genes are made of nucleic acid
instead of proteins, has once said: “Influential ideas are always simple. Since natural
phenomena need not be simple, we master them, if at all, by formulating simple ideas and
exploring their limitations” (cited in: Ptashne and Gann 2002, 59). So let us accept
Waters’ (and Crick’s earlier) claims as necessarily simple ideas to master a complex
reality and take my following arguments as exploring their limitations. Even if we restrict
ourselves to the investigation of sequence specificity of gene products we see that the
organism’s molecular complexity is not specified by its limited number of protein coding
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genes but by what it can do with its genome. I will prove this point with detailed
examples of how nucleotide sequences are activated, selected and created by causally
specific regulatory mechanisms of genome expression. My goal is not to understand the
full complexity involved in the regulation of genome expression, much less so the
biological mechanisms beyond the primary sequence of gene products. This paper has
the limited agenda of giving examples of sequence modifying processes to understand
which agents other than genes carry causal or sequence specificity.
3. Sequence is not destiny: Distributed causal specificity
The view of conformational and informational specificity as selective and exclusive has
recently given way to a picture of both conformational and causal specificity as being
highly distributed, modular and combinatorial. Through the expansive possibilities of
combinatorial associations more sophisticated cellular functions can be achieved and
fine-tuned by increasing the number of interactions any specifying agent can engage in
by virtue of its intrinsic molecular function. Even in prokaryotes, and to a much larger
extent in eukaryotes, the regulation of gene expression works by means of the regulated
recruitment of trans-acting factors (proteins, RNAs and metabolites) into larger
complexes and to cis-acting sequence modules, so that the specificity of an enzyme, a
sequence, transcription or splicing factor comes to depend on its proper recruitment and
combinatorial interaction (Ptashne and Gann 2002; Buchler et al. 2003). Hence a gene
product is specified by a genomic template and the differential recruitment of agents of
genome expression mechanisms that activate and alter the transcript specifically. This
versatility of the genome by means of the combinatorial complexity of its regulation
resolves the ‘N-value’ paradox (Claverie 2001; Harrison et al. 2002): The proportion of
protein-coding sequences indeed seems to decline as a function of complexity, but the
ratio of non-coding DNA rises, and so does the number of functional, regulatory roles
played by non-coding DNA and RNA and other cellular factors that help to translate
sequential information encoded in the genome into developmental complexity (Mattick
2004).
Karola Stotz: 2001 and all that, draft, 11/24/06 9
 “There is increasing awareness that multiple, often overlapping mechanisms exist
for amplifying the repertoire of protein products specified through the mammalian
genome. An expanding array of processing and targeting mechanisms is now
emerging, each representing a potentially important restriction point in the
regulation of eukaryotic gene expression, and each expanding the possibilities
specified by the literal code of the genome. These co- and posttranscriptional
regulatory events include capping, alternative splicing, differential
polyadenylation, RNA editing, nuclear export, alternative decay and degradation
pathways, as well as alterations in ribosomal loading or translation” (Davidson
2002).
Latest estimates place the number of alternatively spliced human genes to over 70%, with
close to 100 genes with over 5,000 splice variants, and the Drosophila record of up to
38,000 temporally and spatially regulated splice variants derived from the Drosophila cell
adhesion molecule gene (DSCAM), and (Kapranov et al. 2005; Celottoa and Graveley
2001; Graveley 2005; Rowen et al. 2002; Leipzig et al. 2004). In some mitochondria of
higher plants a total of more than 1000 C-to-U changes are known to alter the total
coding text of the entire RNA population, mostly within the first two positions of codons,
hence changing the amino acid. The RNA editing of cellular RNAs of many eukaryotic
organisms can result in up to 50% modified adenosine residues in a transcript (Gott and
Emeson 2000). This form of editing is absolutely critical for normal brain function in
humans and very prevalent in mammalian cells with a suspected 85% of all mRNA as a
target (Athanasiadis et al. 2004). A recent study of the architecture of the human
transcriptome paints “a picture of a highly overlapping, complex, and dynamic nature of
the human transcriptome, where one base pair can be part of many transcripts emanating
from both strands of the genome. The data further suggest that base pairs normally
thought to contribute to transcripts from different genes can be joined together in a single
RNA molecule” (Kapranov et al. 2005; see also: Kampa et al. 2004; Cheng et al. 2005).
New metaphors to capture this emerging picture have been suggested:  “the sociable
gene” conveys the interactivity, fluidity and dynamics of the genomic system; to describe
the control of genome transcription Lenny Moss has coined the term of “ad hoc
committees” of molecules convened on the basis of the history of the cell and its
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interaction with the environment (Turney 2005; Moss 2003). There is so much more to
our genome than its officially annotated number of ‘genes’ suggests, and in 2003 the
National Human Genome Research Institute (NHGRI) with launching “ENCODE” has
recognized this. The ENCyclopedia Of DNA Elements Project aims to comprehensively
identify all the functional elements in the human genome, including transcriptional and
other regulatory elements, gene and exon variants, alternative promoters in tissue-specific
gene expression, chromatin-mapping sites, and conserved non-coding elements. The
factors that interactively regulate genomic expression are far from mere background
conditions or supportive environments; rather they are on a par with coding information
since they co-specify the linear sequence of the gene product together with the target
DNA sequence. From this follows the radical thesis of ‘molecular epigenesis’: Networks
of genome regulation made up of cis-regulatory sequences, trans-acting factors and
environmental signals causally specify the physical structure of a gene and the range of
its products through the activation, the selective use, and, more radically, the creation of
nucleotide sequence information (Stotz 2006).
4. The flexible genome: sequence selection
Transcriptional regulation:
(Thesis 1): To restate Waters’ first thesis, he singles out “activated” DNA as the causally
specific agent responsible for the composition of a population of RNAs in a cell. The
default position of eukaryotic DNA is inactivation, and Waters deliberately neglects and
downplays all the processes that are involved to activate DNA as causal agents. Second,
he forgets to clarify between which two states DNA should function as the actual
difference maker: it could be the difference in the linear sequence between any two gene
products, or the difference between two populations of RNAs in two cells of an organism.
The second problem is what is commonly called the foremost ‘problem of development’:
the differentiation of cells from a single cell in multicellular organisms. The peculiarity of
the differentiated cells is that despite their immense differences they all share the same
DNA (with some notable exception as immune cells). Hence the actual difference
between two cells is not their DNA but activating agents such as specific transcription
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factors and inducing signals that co-differ between two cells. They orchestrate the tissue-
dependent and time-specific activation and sequence selection of a subset of ‘genes’ that
translates into different cellular phenotypes. The phenotypic difference between two
daughter cells could result from the expression of different genes (with different causal
specificity) or the time-, tissue- and combination-dependent expression of common genes
(with the same causal specificity). Activation of DNA is therefore a causally specifying
mechanism by determining a particular RNA product to be there. In addition, since
activation selects between different promoters, and is likely to influence co-
transcriptional activities such as splicing and editing, activation is causally specifying the
particular sequence of a RNA product from the same DNA sequence through sequence
selection and creation.
(Thesis 2a): Waters main thesis states the exclusivity of DNA in providing causal
sequence specificity: (with some notable exceptions) only DNA provides the linear
sequence specificity of any gene product. So while we are agreeing in principle that DNA
alone is not the sole source of sequence specificity, I believe my argument presents a
radical shift in focus from (molecular) genetic to (systems biological) distributed
sequence specificity. Against Waters’ almost exclusive notion of specificity in this and
the following section I set a picture of distributed causal specificity, where already pre-
selected and activated DNA shares the stage with the RNA processing machineries of
splicing, editing, modification and translational recoding that further select, modify and
newly create DNA and RNA sequences. All gene expression mechanisms such as
activation or inhibition, splicing, editing and other co- and posttranscriptional processes
have in common the combinatorial interaction of multiple and variable cis-acting
sequence modules both upstream, downstream and within coding sequences that through
their primary sequence or secondary structure formation bind a large range of diverse
trans-acting factors such as proteins and RNAs. These factors either need to be
transported, recruited or induced by intra- or extra-cellular signals and by these means
function as mediators of environmental information to the genome. Most cis- and trans-
acting elements have in common that they are individually weak, variable, and present in
multiple copies. As we now know, “there is little or no constitutive regulation in higher
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organisms; i.e., the differentiated state of normal cells is unstable and the environment
regulates gene expression” (Bissell 1981, 27; quoted in Bissell 2003). Because of the
structure of their complex, modular, but weak promoter sequences gene expression in
eukaryotes always requires the recruitment of a large transcriptional machinery of trans-
acting factors to the cis-acting modules through activators (another kind of trans-acting
factors that bind to very distant cis-acting sequences, the enhancers). The exact order and
nature of their recruitment is still largely unknown, we know, however, that the full
machinery comes in the form of separate complexes often made up by a large number of
proteins (see Figure 1): the activator complex assembles at the enhancer (enhanceosome)
to recruit the chromatin remodeling complex (to make the DNA accessible) and the
TATA-binding proteins and associated factors, which bind to the TATA site of the
promoter to recruit the transcription enzyme polymerase, specific transcription factors
and transcription cofactors. It is the specific recruitment of transcription factors to
varying complexes by trans-acting factors (proteins, RNA and environmental factors)
that imposes their specificity.
Through the differential use of alternative promoters, transcription start sites and
transcription termination sites activation can at the same time be the pre-selection of the
actual sequence of the gene. The differential use of promoters can also specify splice site
selection when alternative exons can come with their own promoter (Dorn et al. 2001;
Tasic et al. 2002). Some of the components of the transcription machinery will
subsequently move along with the polymerase during the transcriptional process and may
interact with the capping, splicing, polyadenylation and editing machinery (Ptashne and
Gann 2002; Davidson 2001). Cells constantly response to intra- and extracellular signals
such as a hormonal or nutritional changes with a change in gene expression mediated
through the environment-specific use of regulatory elements (Ptashne and Gann 2002). In
other words RNA and proteins relay environmental information to the genome. A
common mechanism of induction is the phosphorylation of transcriptional regulators that
changes their conformational specificity. Specificity is imposed by environmental
induction of activators, differential recruitment and combinatorial control.
Karola Stotz: 2001 and all that, draft, 11/24/06 13
Insert figure 1 about here
One hallmark of postgenomic biology is the recognition of an extension of the
possibilities specified by the literal code of the genome through the extensive
amplification of the repertoire of RNA and protein products. This change in focus is
mirrored by the terms ‘histone code’ and ‘cellular code’7, coined for co-specifying the
activation, selection and modification of DNA through transcriptional, co- and post-
transcriptional processes. These mechanisms of causal specificity introduce “a new
element of difficulty in understanding the transmission of information from the DNA
code to the functioning organism” (Eisenberg et al. 2006). The following section
highlights agents involved in the final selection of DNA sequences especially through
alternative splicing. Together with the mechanisms of activation and pre-selection they
present ‘conservative’ cases of shared causal specificity because leave intact, however
split up, the linear order of the original sequence in the gene product.
Alternative Splicing:
In eukaryotes, the DNA sequence is transcribed into a pre-messenger RNA from which
the final RNA transcript is processed by cutting out large non-coding sequences, called
introns, and splicing together the remaining, mostly but not always coding sequences,
called exons. Biologists speak of alternative cis-splicing when more than one mature
mRNA transcript results from these processes through the cutting and splicing of
alternative exons. This is a very prevalent mechanism in complex organisms that affects
quantitative and qualitative control of gene expression and the generation of protein
diversity from a single DNA precursor. Agents other than the original coding sequence
have to provide sufficien tspice-site specificity controlling this diversification.
Pre-mRNA splicing is the process by which two successive transesterification reactions
                                                 
7 The histone code is the sum of all chromatin- and DNA-modifying chemical complexes that imprint DNA
sequences by rendering them inaccessible to the transcriptional machinery. The cellular code is the
combination and their potential of combinatorial interaction of all available transcription factors, functional
RNAs and inducing agents in a cell at one point in time. The term ‘code’ refers to the combinatorics of all
these factors as conveying the ‘meaning’ to the gene expression machinery.
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cleave the upstream exon from the intron and ligate it to the downstream exon. This takes
place on the spliceosome, a dynamic complex of small nuclear RNAs/proteins and
extrinsic SR protein factors assembled on the juxtaposed 5' and 3' splice sites. The splice
site sequences are generally small and weak and not sufficient to specify splicing.
Splicing specificity is imposed by the assistance of additional cis-acting elements in
either of the adjoining introns or the exon itself and by trans-acting factors binding to
them. While exonic and intronic splicing enhancers (ESE and ISE) positively stimulate
the spliceosome assembly at certain sites, exonic and intronic splicing silencers (ESS and
ISS) block certain splicing choices (see figure 2) (Smith and Valcarcel 2000). In other
words, the availability of certain trans-acting factors and the differential and
combinatorial binding of spliceosomal binding RNAs and proteins to splice sites and
regulatory sequences (the ‘cellular splice code’) seems to be the major contributor to
splicing specificity.
Insert Figure 2 about here
Occasionally the formation of a double-stranded RNA secondary structure can add
specificity, similar to certain editing mechanisms. A mechanism called “variable window
binding” between sequences in an intron separating a canonical exon from its mutually
exclusive downstream exons with their partially overlapping and complimentary
sequences seems responsible for the mutually exclusive splicing of alternative
downstream exons to a canonical upstream exon in the Drosophila Dscam gene, which
contains four clusters of a large number of mutually exclusive alternative exons
(Anastassiou et al. 2006; Graveley 2005). A recent discovery has shown the provision of
splicing specificity by RNA modification via a small nucleolar (sno) RNA (Kishore and
Stamm 2006). This and similar examples show the interdependency of splicing, RNA
modification guided by snoRNA and RNA editing (Bachellerie et al. 2002; Flomen et al.
2004). Three major mechanisms are known that change the “cellular code” for splice site
selection: the de novo synthesis of splicing proteins, the activation of these proteins
through phosphorylation, and a change in localization of splicing regulatory proteins
from the nucleus into the cytosol or into stress-induced nuclear bodies (Stamm 2002;
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Shin and Manley 2004). “The combinatorial mechanism for the control of alternative
splicing … could allow cells to adjust splicing outcome (and consequently which proteins
they express) rapidly in response to intracellular or extracellular cues, as well as
contributing to the generation of protein diversity” (Bradbury 2005). In other words, the
cellular context imposes splice site specificity.
(Thesis 2b): Under certain, restrictive conditions Waters is willing to extend causal
specificity to splicing and editing agents, namely when different splice variants exist in
the same cell at the same time; this is not credited when each cell produces its own splice
variants, which would render the regulatory machinery as background condition. For the
argument’s sake, I interpret Waters to reason as follows: From an observer’s viewpoint,
in certain cellular conditions a gene is always specifying a particular splice variant, hence
it holds the causal specificity. However, from the viewpoint of the DNA sequence or the
entire cell, the relevant splicing and editing mechanisms are the providers of sufficient
sequence specificity for the right product. In reality, however, most cells just differ in
their ratios of a particular splice variant: “for most alternatively spliced transcripts there
is no 'default' or unregulated state; instead, the ratio of alternative splice forms observed
for a given pre-mRNA results from a balance between positive and negative regulation”
(Ladd and Cooper 2002, 3; e.g. Celottoa and Graveley 2001; Athanasiadis et al. 2004).
(Thesis 3): Waters names prokaryotic gene expression and the specification of pre-
mRNA as the clearest case for his (preferred but limited) exclusive DNA causal
specificity thesis. However, not even in prokaryotes or in the production of preliminary
mRNAs in eukaryotic cells does the DNA sequence exclusively specify the products. We
now know that there exist RNA editing and modifying mechanisms in bacteria, and that
transcription in eukaryotes is being carried out by what has come to be known as the
cotranscriptional machinery or mRNA assembly line. This means that there is indeed no
time at which a fully sequenced pre mRNA exists in the cell.
The Cotranscriptional machinery
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Although all mechanisms of DNA expression and regulation have their biochemical
identity, all of them feature in an “extensive network of coupling among gene expression
machines”. It is now clear that alternative splicing does not represent a distinct and
decoupled step but is tightly coupled to transcription, polyadenylation, RNA editing,
RNA surveillance and transport. “Recent studies suggest that this task is facilitated by a
combination of protein–RNA and protein–protein interactions within a ‘mRNA factory’
that comprises the elongating RNA polymerase and associated processing factors. This
‘factory’ undergoes dynamic changes in composition as it traverses a gene and provides
the setting for regulatory interactions that couple processing to transcriptional elongation
and termination” (Bentley 2005). Polymerase II and many other transcriptionnal proteins
cooperate with the cotranscriptional processing factors. For instance, some SR proteins
involved in the spliceosome have been known to react with transcription factors, while
other proteins even exhibit a dual function as transcription and splicing regulator
(Maniatis and Reed 2002; Bentley 2002). The cotranscriptional assembly of the
spliceosome in this ‘mRNA assembly line’ suggests profound implications for the
regulation of splice site choice. Splicing has also been implicated in downstream
processes such as RNA transport, stability, translation, location (Black 2003, 323). In
addition, important links between RNA editing and other co- and posttranscriptional
events that regulate gene expression have been suggested (Davidson 2002). These co-
transcriptional agents (cis-regulatory elements, trans-acting factors, intra- and
extracellular signals) in combinatorial interplay with each other share causal specificity
with genomic coding sequences in the production of gene products through their
involvement in sequence selection (e.g. splice-site specificity) and sequence creation (e.g.
editing-site specificity).
Other sequence selection mechanisms
Beside the ‘normal’ splice variants the genome produces a large variety of transcripts that
are even harder to attribute to a single nominal gene.8 Many transcripts contains exons
from adjacent genes and even pseudogenes that are 'co-transcribed' to produce a single
                                                 
8 For a more extensive list of such cases see (Stotz 2006; Griffiths and Stotz 2006) and
Griffiths and Stotz’ “Representing Genes” website: www.representinggenes.org
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pre-mRNA (Communi et al. 2001; Kapranov et al. 2005; Finta and Zaphiropoulos 2000b,
2002). Such cotranscription may be produced by the insufficient termination efficiency of
polymerase II or by a process that in prokaryotes has been called antitermination. In the
latter case a regulatory protein induces changes in the termination properties of the
polymerase. Many pseudogenes are processed, and while often we don’t know their
function, in some cases their mRNA seem to exert a stabilizing effect on the transcript of
their homologous, functional gene (Hirotsune et al. 2003). Alternative gene products may
be derived from so-called 'overlapping genes' including transcripts from the antisense
strand, or read in an alternative reading frame (Blumenthal et al. 2002; Coelho et al.
2002). Instead of receiving mutually exclusive alternative transcripts from the same DNA
sequence, as is the case with all alternative splicing and many overlapping phenomena,
multiple simultaneous transcripts can occur, as is the case of the parallel processing of
functional non-coding RNAs (such as microRNAs and snoRNAs) from the intronic
regions of the transcript. These RNAs may be involved in the regulation of the coding
transcript of the same gene, but need not be. In all of the above instances the selective use
of nucleotide sequences through a range of transcriptional, co- and post-transcriptional
mechanisms co-specify the linear sequence of the final product.
5. The versatile genome: sequence creation
In the following ‘radical’ cases of sequence specificity the linear sequence of the final
product is not mirrored by the DNA sequence but is extensively scrambled, modified or
literally created through a variety of co- and post-transcriptional processes, which often
are interdependent with mechanisms of sequence activation and selection. All of the
following cases are even stronger counterarguments to Waters main thesis (2b) of
exclusive DNA sequence specificity than any of the ‘conservative’ cases provided above.
Trans-splicing
Biologists speak of trans-splicing when a final mRNA transcript is processed from two or
more independently transcribed pre-mRNAs.9 These separate pre-mRNAs can be derived
                                                 
9 For examples and diagrams of trans-splicing cases see www.representinggenes.org
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from different DNA sequences or from multiple copies of transcripts from the very same
sequence. The latter case allows the inclusion of multiple copies of the same exons or to
scramble the original order of exons in the final transcript (Finta and Zaphiropoulos
2000a). In other words, trans-splicing is changing the linear order of the original DNA
sequence in the gene product, and co-linearity is the hallmark of Crick’s and Water’s
sequence specificity. Alternative exons can feature their own promoter that specify their
individual selection while their inclusion in the final transcript must involve trans-
splicing (Pirrotta 2002). Different trans-splicing pathways exist in nuclei and organelles,
where they mostly resemble their cis-splicing counter parts. Mechanisms for splicing in
trans are supported by splicing agents that seem to be split versions of their equivalent
cis-acting agents (Caudevilla et al. 2001). Split introns can assemble a split spliceosome
complex to provide specificity for trans-splicing in the nucleus and for spliced leader
trans-splicing in kinetoplastid, while split self-splicing group II introns support trans-
splicing in plant organellar genomes (Rivier et al. 2001; Sturm and Campbell 1999;
Malek and Knoop 1998; Wissinger et al. 1991). So while we still don’t know the exact
inducing agents for the specific recognition of the autonomous pre-mRNAs, finding
related mechanisms to cis-splicing should not surprise; in genes with very long introns
splicing specificity happens almost in trans. Hence as far as we know similar agents and
mechanisms to alternative cis-splicing provide specificity to trans-splicing.
RNA editing
RNA editing is another and very prevalent10 mechanism of sequence modification that
can significantly diversify the transcriptome or proteome (the total complement of final
transcripts or proteins in the cells of an organism). Whereas most other forms of co-
transcriptional modification of mRNA (capping, polyadenilation and cis-splicing) can be
said to retain the correspondence of coding sequence and gene product (even though
certain coding and noncoding regions have been cut out), RNA editing disturbs this
correspondence, in some cases to a very large extent. But while trans-splicing did so by
                                                 
10 See (Gott and Emeson 2000) for a very good overview.
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scrambling the order of the primary DNA sequence, editing changes the primary
sequence of mRNA during or after its transcription via the site-specific insertion or
deletion or substitution of nucleotides (cytidine-to-uridine and adenosine-to-inosine
deamination, uridine-to-cytidine transamination) (Gray 2003). This creation of
‘cryptogenes’ affects most kinds of RNA (mRNAs, tRNAs, rRNAs, and 7 SLRNA) and
can potentially have radical effects on the final product. U insertion or C-to-U
conversions can lead to the creation of new translation start and stop codons (e.g.
trypanosomatid protozoa, plant organelles, humans), while U-to-C changes can remove
them (eg. Plants). Editing events within coding sequences reach from widespread
nucleotide insertions (‘pan-editing’ in kinetoplasts and Physarum mitochondria, where
over 50% of the final mRNA can be the product of editing) to singular amino acid
substitutions due to C-to-U, U-to-C, and A-to-I changes, enlarging the number of protein
isoforms created from a transcript. Other consequences include frameshifting between
alternative ORFs (paramyxoviruses), alterations in splice sites by A-to-I conversion in
mammals, and other alterations within introns and 5' and 3' untranslated regions (UTRs)
potentially affecting mRNA stability, transport, translatability, and processing. This
phenomenon provides a potential break in the central dogma according to which coding
information must be template derived, and in many cases, as seen in the human brain, the
editing-derived coding information is essential for the normal functioning of the
organism.
Just a few of the myriad of different editing mechanisms are explained below that focus
on agents that provide editing specificity. The main specificity-providing agent involved
in nucleotide insertion/deletion in kinetoplasts are trans-acting guideRNAs (gRNAs) that
bind to a complementary ‘anchor sequence’ just downstream of the editing sites (see
figure 4). This anchor duplex directs the endonucleolytic cleavage event that initiates the
editing cycle just upstream of the duplex. gRNAs act as templates to encode insertion or
deletions of uridines into the nascent mRNA transcript due to their incomplete
complementarity to the nascent mRNA strand. Bulges in the gRNA indicate insertion
sites for the mRNA, while bulges in the mRNA get deleted. gRNAs may fold into a
secondary structure to bind trans-acting factors such as a ribonucleoprotein (gRNP)
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complex. Highly diverse mechanisms are utilized to accomplish the same end in different
organisms. Insertional and deletional editing can occur either cotranscriptionally or
posttranscriptionally with varying editing pathways. In cases where editing is tightly
connected to transcription RNA polymerase could be involved in the recognition of
editing sites.
Insert Figure 3 about here
A-to-I editing of cellular RNAs of many eukaryotic organisms modifies the adenosine
residues to inosine, which will be translated into guanine. While the total number of
known genes is still rather small (e.g. the serotonin receptor 5-HT2C), recent estimates
speculate that one in a thousand nucleotides in human brains are edited. Editing requires
a partially base-paired RNA foldback structure, often provided by a pair of inverted Alu
repeat sequences (see figure 5). These base-pairing events, however, don’t provide the
template for editing events as in the case of gRNA but mainly provide a substrate for the
editing enzyme ADAR (adenosine deaminase that acts on RNA) (ADAR). The basis for
the observed editing selectivity is still poorly understood, but it seems that mainly A-to-C
mismatches (leading to G-to-C matches) and A-to-U matches (leading to G-to-U
mismatches) are targeted for editing, partially guided by sequence biases within
neighboring bases (Athanasiadis et al. 2004). As said before, one function of editing can
be to create alternative splice sites. ADAR2, for example, produces four different splice
variants of the mammalian editing enzyme ADAR2. One particular splicing event that
creates a short ADAR2 protein with no editing activity relies on the gene’s own product,
ADAR2, to edit this mRNA. In other words, ADAR2 controls its own level of expression
through a negative feedback mechanism. When ADAR2 levels get too high, it edits its
own RNA to shut down its expression (Rueter et al. 1999). As is the case with splicing,
editing specificity seems to be distributed between cis- and trans-acting factors as well
cell-signaling factors inducing certain trans-acting agents.
Insert Figure 4 about here
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Another common mechanism able to disrupt the colinearity between DNA sequence and
final product is the nonstandard translational recoding of mRNA. The three different
ways through which the translational machinery is able to recode the message are
frameshifting, programmed slippage or bypassing, and codon redefinition (Baranov et al.
2003). The details of transcriptional activation, alternative splicing, trans-splicing, RNA
editing, and translational recoding are meant to show that the specifying relationship
between DNA and gene product is indirect, mediated and specifically intervened by other
sequence specifying agents (table 1).
             Insert Table 1 here
6. By way of conclusion: The postgenomic ‘gene’ concept
There are several general conclusions to be drawn from the mechanisms of sequence
activation, selection and creation outlined in the last two sections:
The Reactive Genome
1. The causal specificity for the linear sequence of a final gene product, including pre-
mRNAs, is distributed between the local DNA sequence, cis-acting sequences, trans-
acting regulators, environmental signaling factors, and the contingent history of the cell
(the cellular code) (see Table1 for an overview). In certain extreme cases the guide RNAs
(or their DNA sequences) together provide the template (‘gene’?) for the final product
rather than the nominal gene, but nobody would commonly call the guide rDNA the gene.
Many if not most agents involved in the regulation of gene expression of higher
organisms not only must work in interaction with other agents in order to achieve full
specificity, which is imposed by regulated recruitment and combinatorial control. The
modular organization of genes, cis-regulatory sequences and trans-acting factors into
actively distinct subunits (DNA binding sites, protein-protein and protein-RNA
recognition sites, and catalytically active sites) is actively supporting this distributed and
combinatorial specificity. Many people have argued that greater complexity is achieved
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not by the addition of exclusively specific agents but by increased regulation, interaction,
integration and the combination of structural-analog with informational-digital
specificity.
2. One might concede that while any local DNA sequence (‘gene’) may indeed only
partially specify its product, the genomic sequence as a whole via cis-acting sequences
and trans-acting genome products is indeed sufficient for full causal specificity. Hence
sequence specificity and causal agency remains with the genome. Since higher
eukaryotes have no default transcriptional activation or splicing pattern, since
information is provided by difference-making RNA and protein factors which in turn
need to be recruited or turned on by external factors. Certain RNAs and proteins undergo
crucial changes in shape in response to signals, which render them active and impose
their causal specificity (Ptashne and Gann 2002, 6-7). By this means they relay
difference-making environmental information to the genome. While many genetic
accounts describe the environment as merely permissive, in many cases of gene
expression the environment actually provides instructional specificity, including for gene
products.
“Organisms have evolved [a reactive genome] to let environmental factors play major
roles in phenotype determination. […] In instructive interactions, a signal from the
inducer initiates new patterns of gene expression in responding cells. […] It is usually
assumed that the developing organism’s environment constitutes a necessary
permissive set of factors, whereas the genome provides the specificity of the
interaction. In phenotypic plasticity, however, the genome is permissive and the
environment is instructive” (Gilbert 2003, 92).
3. Waters’ focus on the specificity of coding sequences shares the bias of the last 50
years of genetic research in its focus on (protein) coding genes while it neglects our
growing understanding that the complexity of higher organisms lies not in its number of
genes but within the flexibility, versatility and reactivity of its whole genome.
Complexity is not encoded in the literal sequence of coding genes but in the processes
that can amplify this information. These regulatory mechanisms involve among other
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agents a large number of different non-coding RNAs and non-coding DNA sequences
with important binding or structural domains, and even transcriptional capacity, for the
longest time dismissed as ‘junk’ (Levine and Tjian 2003; Buchler et al. 2003). “We
continue to learn new ways in which nature has exploited the specificity of interactions
between RNA and nucleotide sequences. We now know that RNA, after being
transcribed from DNA, can feed back to direct modifications of the genome. These
modifications can be inherited through cell divisions and influence development”
(Kawasaki and Taira 2004). It may be that the “explosion in complexity in virtual all
systems occurred as a result of advanced controls and embedded networking, most of
which is invisible to the observer”. Some people now believe that we are at the brink of a
“digital revolution” of an RNA – controlled parallel system of regulatory control (Mattick
2004, 320).
From Pathways to Networks:
4. Waters’ analysis is built on an outdated model of pathway analysis that is in danger of
overstating the importance of single nodes and the linear sequence of events. “Feedback
loops and back-up pathways have been invoked to account for these properties. […] A
more flexible and fluid view of the relationships among these signaling and regulatory
systems allows for the same net result without invoking a predetermined mechanism for
it. The malleability and versatility of gene networks and their ability to find new solutions
when constituents are changes, help to account for the properties of robustness, buffering
and emergence“ (Greenspan 2001, 386, my emphasis). This point restates some newer
criticism against the central dogma not as necessarily literally wrong but as misdirecting
research into dogmatic pathway analyses and away from systems thinking (Werner
2005).
5. The Central Dogma has been enormously influential in molecular biology in the last
50 years. Several have claimed to prove it wrong, reverse transcriptase and prions being
the main contenders. The flow back from RNA, however, was never explicitly excluded
and prions don’t confer sequence specificity. The shown phenomena, however, should
provide a serious blow to the central dogma according to which sequence information or
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causal specificity should be template-derived. This dogma now turns out to give a very
limited and in its exclusity wrong account of the origin of sequence information. We
don’t find ourselves with a reverse flow, but with a range of alternative sources of
sequence information, some of which are derived from secondary products and
environmental factors.
Parity between similar functional roles
6. Last but not least, Waters misunderstands the principle of ‘causal parity’, which
“derives its name from Oyama's earlier call for 'parity of reasoning' when thinking
about the roles of DNA elements and other developmental resources. She argued that
if one of the above distinctions applies to some but not all DNA elements and also
applies to some non-DNA influences in development, we should treat both the DNA
and the non-DNA factors alike in the area of theory where the distinction is useful. In
order to be able to follow this principle of parity it is essential not to build grand,
metaphysical distinctions, like that between form and matter or information and
matter, on top of the many empirical differences between the roles of DNA elements
and the roles of other causal factors in development … DNA does play a distinctive
set of roles in development, but it does not play just one role (partly because DNA
elements are themselves so diverse) and the important roles of those various DNA
elements are sometimes played by non-DNA factors in development" (Griffiths and
Gray 2003, 421).
When distinguishing different causal processes (italized below) in an organism, there are
always more than one agent fitting this causal role: Sequence specificity is held by DNA,
but also by splicing and editing agents, as well as other regulatory mechanisms that are
involved in modifying the primary sequence of RNA. Enzymatic activity has for the
longest time been attributed to proteins alone but is, as we now know, regularly achieved
by tertiary RNA structures (ribozymes). Protein transcription factors now have to share
their fame with regulatory non-coding RNAs and inducing environmental factors such as
lactose in the regulation of genome expression; and unrelated to this topic but important
nonetheless to the very idea of parity: though by different means which can be
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distinguished if useful, organisms inherit a good deal more beside their DNA. Alone at
the molecular level there is the histone code, structural components of the cell such as
organelles and membranes, maternal RNA and transcription factors. And at higher levels
of organization we have whatever else is provided by the parental generation in form of
an ‘ontogenetic niche’ for the zygote, fetus, and born individual in a providing
environment.
Focusing on the cutting-edge of contemporary genomics can induce an extremely
deflationary, postgenomic view of the gene. As Falk suggested already 20 years ago:
“Today the gene is … neither discrete … nor continuous …, nor does it have a constant
location …, nor a clearcut function …, not even constant sequences … nor definite
borderlines” (Falk 1986, 169). Some molecular biologists, realizing that the concepts of
‘gene’ transcription or ‘gene’ expression may not suffice to capture the complex
architecture of the transcriptome of many eukaryotes have proposed the more general
term of “genome transcription” to allow for the incorporation of RNA transcripts that
contain sequences outside the border of canonical genes. From this new perspective the
classical molecular conception of genes seems like “statistical peaks within a wider
pattern of genome expression” (Finta and Zaphiropoulos 2001, 160). Recent investigation
of the complexities of the human transcriptome supports these views (Kapranov et al.
2005). If correct, these results have important implications for the definition of a gene,
and for the relationship between genotype and phenotype (Griffiths and Stotz 2006, in
press). In contemporary postgenomic bioscience genes are hard to define as a
straightforwardly structural entities, but a purely functional definition as suggested by
Snyder and Gerstein would also run counter to some of our longstanding practices (e.g. to
allow for alternative splice forms without increasing the number of genes11) (Snyder and
Gerstein 2003). Or we just throw overboard these old stereotypes and the long-held ideal
that a gene definition must combine functional and structural criteria, and say that genes
                                                 
11 Celera emphasizes the importance of alternative splicing in their definition of a gene as "a locus of
cotranscribed exons". Ensembl's GeneSweepstake Web page goes into the same direction with their
definition of a gene as “a set of connected transcripts ... [which] share at least part of one exon in the
genomic coordinates”. Both definitions partition the genome into regions of connected exons defined by the
transcription process. By these definitions trans-spliced, polycistronic transcripts are split into multiple
genes.
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are ways in which cells utilize available template resources in almost anyway they like to
create biomolecules that are needed in a specific place at a specific time: genes are
“things an organism can do with its genome” (Stotz et al. 2006). The deflationary
postgenomic gene concept, together with distributed causal specificity provided by
environmentally induced combinatorial control and differential recruitment, forces us to
look beyond exclusive specificity, single gene searches, the increasingly restraining
central dogma, and linear pathway analyses towards the new science of postgenomic and
systems biology.
7. An outlook to the 21st century: Postgenomic biology
The entry into post-genome biology has been accompanied by many phrases like ‘from
sequence to biology’ or ‘to the center of biology’ which suggest a move from reductionist
molecular biology to systems biology (Stein 2001; Lander and Weinberg 2000).
Metaphorically speaking, while the former has lost the forest (the whole network, the
whole system) for keeping the trees (single genes/molecules/sequences/nucleotides), the
latter tries to see the forest again with its focus on the integration of networks of genes,
protein, gene regulatory functions, metabolic products and their interactions12. Since then
systems biology developed into a new discipline with an increasing number of new
research and training centers popping up worldwide. It aims at an in-depth understanding
of living organisms at system-level firmly grounded firmly to the molecular level. Hence,
their relationship is not one of a simple reduction: systems biology utilizes molecular
biology as providing the raw data in need of integration and interpretation in light of the
system as a whole. Postgenomic biology accepts molecular research as a legitimate
investigative strategy but uses a system-level explanatory strategy.
“Twentieth century biology triumphed because of its focus on intensive analysis
of the individual components of complex biological systems. The 21st century
discipline will focus increasingly on the study of entire biological systems, by
attempting to understand how component parts collaborate to create a whole. For
                                                 
12 I am owing this metaphor to Sandra Mitchell.
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the first time in a century, reductionists have yielded ground to those trying to
gain a holistic view of cells and tissues” (Lander and Weinberg 2000, 1781).
In other words, postgenomic biology has as one of its goals to reassemble the living
organisms. But it also understands that the essence of systems biology lies not in
computational power or high-throughput analysis – even though that is a big part of it - it
is all about dynamics, the quantitative analysis of biological processes over time and
space. Thus, systems biology seeks to explain biological phenomena not on a gene-by-
gene basis but through the interaction of all the individual components in a cell or
organism.
The postgenomic gene concept that centrally features in this new science owes its
physical structure and biological function to time-and-tissue-dependent regulatory
mechanisms of genome expression, with which it has to share causal specificity. These
mechanisms themselves have their specificity imposed by combinatorial control, which is
ultimately dependent on contingent factors. Many core regulatory processes are by
default inactive, and when activated generally unstable unless stabilized by the contingent
interaction with multiple other core processes. Most interactions are weak, transient, and
reactive to the combinatorial influence of new participants. “By compartmentalizing
different core processes and rendering their linkages to each other highly contingent, i.e.
regulated by circumstance, core processes can evolve greater specializations” (Moss in
press). Hence the focus of postgenomic biology is no longer on any single gene with its
exclusive causal specificity but on the network of regulatory mechanisms of genome
expression with distributed specificity, of which the intra- and extracellular environment
is a central determining part. Although history reminds us that no victory is final, systems
biology with its profound change in the culture and content of the life sciences seems to
provide a harsh blow to the success of reductionism. It’s successes are a) the nearing
completion of a complete list of parts of eukaryotic cells in the form of multiple ‘omic’
enterprises and b) a reasonable complete diagram of their interaction not to far in the
future. However:
The cell is not hard wired, therefore a “wiring diagram” only provides, after much
analysis, a combinatorically rich repertoire of circuit modules, particular subsets
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of which are selected by particular environments. And because a cell’s
environment is in fugue, the problem of systems biology is understanding the
rules of subset selection, and connecting recurrent functional modules to
phenotype” (DeLisi 2004).
So it remains questionable that both ingredients alone give us the necessary and sufficient
conditions for understanding the complexity of a living organism or the development of a
particular trait, even if that trait is reduced to a single mRNA product.
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Figure 1
Figure 1: Programmatic schema of the diverse 3’ and 5’ cis-regulatory modules and its chromatin
remodeling and diverse transcription complexes. Shown are some auxiliary looping factors that help
bringing the complexes into contact, especially the mostly very distant enhancer with its activators, who is
recruiting several of the other complexes.
Figure 2
Figure 2: Programmatic schema of the distribution of cis-regulatory splicing modules for one exon.
Beside the canonical (plus possible non-canonical) splice sites (here very simplified), there exist a range of
enhancers and inhibitors within the exon and in the flanking introns (shaded boxes). Multiple copies of the
same sequence (colored in the same shade) bind the same splicing factors, either serine/arginine-rich (SR)
splicing proteins or heterogeneous nuclear ribonucleoproteins (hnRNPsFigure 3:
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Figure 3
Figure 3: U-insertion and U-deletion in Kitanoplasts via guideRNA (gRNA). The gRNA forms binds to
its 8-nucleotide-long complementary 3’ anchor sequence in the pre-mRNA. The rest of the gRNA forms an
incomplete double strand with the pre-mRNA, with bulges and loops in the gRNA presenting the editing
targets for insertion, and in the mRNA for deletion. The edited mRNA matches the gRNA
Figure 4
Figure 4: A-I nuclear RNA editing via exon-intron double stranded RNA formation (often by means
of reverse Alu repeats of which many coding genes contain several copies. For simplicity only one editing
site is shown, but the number is often much higher (around 20 editing sites in one dsRNA formation) and
negatively correlated with the distance between the two Alu repeats.
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Table 1
Table 1: Elements with sequence specificity in eukaryotic genome expression. The middle column the
transcriptional and translational stages of nucleic acid from the packaged DNA over RNA to the amino acid
sequence. The left side depicts the different cis-regulatory sequences involved at different stages of genome
expression, while the right side shows the divers trans-acting factors such as transcription factors, splicing
proteins and ncRNA and environmental inducers.
Regulation of Genome expression
Regulatory sequence
Sequence biases
TTS
3' untranslated region
other reg. sequences
Splice sites
Intronic/exonic enhancer
intronic/exonic silencers
Cis-regulatory sequence
foldback structures
sequence biases
Premature stop codon
other sequence elements
Cis-regulatory modules
Enhancer
Promoter
TSS, 5' UTR
Translational recoding
Sequence selection
Sequence creation
Polyadenylation
Stability and Transport
Sequence creation
Cis-splicing trans-splicing
Sequence selection
Sequence creation
RNA editing/modification
Sequence creation
Transcription elongation
Sequence selection
Chromatin configuration
DNA methylation
Transcription activiation
Sequence selection
Ribosome
Associated factors
Environmental agents
Enzymes
other trans-acting factors
environmental agents
Spliceosome
(RNA-protein complex)
add. editing agents
environmental inducers
Editiome
(RNA-protein complex)
add. editing agents
environmental inducers
Polymerase
Transcription factors
Chromatin remodeling
Enhanceosome
Transcription factors
Environmental inducers
